Indications
Empagliflozin is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It is also used to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus who already have established cardiovascular disease.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor. The SGLT2 co-transporters in the kidney take glucose back into the body from the glomerular filtrate. When empagliflozin blocks them, it produces a glucuretic effect, which means less glucose is reabsorbed by the kidney and the renal threshold for glucose falls. More glucose is then passed out in the urine. This helps reduce hyperglycaemia, and it also assists weight loss and lowers blood pressure.
Pregnancy & Breastfeeding
Nobody has done adequate, well-controlled studies of Empagliflozin in pregnant women. So a doctor should prescribe it during pregnancy only if the likely benefit justifies the possible risk to the fetus.
It isn't known whether Empagliflozin passes into human milk. It is not recommended while breastfeeding.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.